Neuroendocrine Tumors (diagnosis) < Neuroendocrine Tumors (drug therapy) < Neuroendocrine Tumors (economics)

Facettes :

List of bibliographic references indexed by Neuroendocrine Tumors (drug therapy)

Number of relevant bibliographic references: 18.

Ident.	Authors (with country if any)	Title
001318 (2011)		Intra-arterial treatment with 90yttrium microspheres in treatment-refractory and unresectable liver metastases of neuroendocrine tumors and the use of 111in-octreotide scintigraphy in the evaluation of treatment response.
001348 (2011)		Incremental diagnostic value and impact on patient management of somatostatin receptor scintigraphy with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors.
001700 (2010)		Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin.
001749 (2010)		Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
001970 (2010)		Gene expression of somatostatin receptor 4 predicts clinical outcome of patients with metastatic neuroendocrine tumors treated with somatostatin analogs.
001E59 (2009)		High-administered activity In-111 octreotide therapy with concomitant radiosensitizing 5FU chemotherapy for treatment of neuroendocrine tumors: preliminary experience.
002600 (2007)		Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours.
003230 (2003)		Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors.
003630 (2001)		[Role of somatostatin analogs in the treatment of neuroendocrine tumours].
003633 (2001)		[Medical treatment of digestive neuroendocrine tumours].
003686 (2001)		Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.
003B53 (1999)		Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors.
003D66 (1998)		The octreotide suppression test and [111In-DTPA-D-Phe1]-octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment.
004070 (1997)		Octreotide scanning for carcinoid tumours.
004300 (1996)		Somatostatin receptor imaging: predictive and prognostic considerations.
004395 (1996)		Indium-111-pentetreotide uptake in endocrine tumors and lymphoma.
004654 (1995)		MIBG and radiolabeled octreotide in neuroendocrine tumors.
007C10 (????)		[Imaging and radioguided surgery of tumors NETs].

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Neuroendocrine Tumors (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Neuroendocrine Tumors (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Neuroendocrine Tumors (drug therapy)
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024